Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Pelles Sharon
23 years of experience
Clinic is certified :
Carcinomatosis treatment cost in Israel typically involves specialized diagnostics like a histopathology revision which runs $500 to $800 and primary surgical interventions. A major procedure such as Hyperthermic Intraperitoneal Chemotherapy (HIPEC) ranges from $61,200 to $95,900. Total expenses depend on the clinical stage, length of hospitalization, and the hospital's public or private status. Patients often save between 30% and 80% compared to healthcare costs in the United States. Tel Aviv and Jerusalem are the primary medical hubs for these oncology services.
Typical Carcinomatosis Treatment Costs in Israel
Bookimed Expert Insight: For patients with digestive system cancers, specialized expertise in systemic and surgical treatments is vital. Sourasky Medical Center (Ichilov) features leading experts like Dr. Pelles Sharon, who trained at the Royal Marsden for gastrointestinal oncology. Patients seeking personalized care may prefer Assuta Medical Center, where they can personally select their attending physician. Sourasky reports a 90% oncology treatment success rate, offering high-value multidisciplinary care for over 400,000 annual patients.
| Israel | Turkey | Austria | |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $61,200 | from $22,500 | from $40,000 |
Dr. Pelles Sharon specializes in advanced cancer treatments, including HIPEC for carcinomatosis, at Sourasky Medical Center.
Professor Ofer Merimsky brings over 41 years of experience of oncology experience, specializing in sarcoma and bone tumors at Sourasky Medical Center.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
The primary treatment for peritoneal carcinomatosis in Israel is a combined protocol of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. This approach removes visible tumors before circulating heated chemotherapy within the abdomen. Specialists at JCI-accredited centers like Sourasky Medical Center and Sheba Medical Center perform these complex procedures.
Bookimed Expert Insight: While many search for the lowest cost, Israeli packages reveal a critical stay-length difference. Sheba Medical Center bundles a 14-day hotel stay into their $68,000 package. This supports the intensive 6–12 month rehabilitation period often required. Sourasky Medical Center reports a 90% oncology success rate. Choosing a center with high patient volumes and integrated recovery housing is vital for managing post-operative needs.
Patient Consensus: Patients emphasize that while this treatment can significantly extend life, recovery is a long journey. Many suggest preparing for significant pain and potential infections during several months of rehabilitation.
Less invasive options for advanced peritoneal carcinomatosis in Israel focus on drug delivery and targeted technology. Pressureized Intraperitoneal Aerosol Chemotherapy (PIPAC) delivers meds via laparoscopy. It uses lower doses with fewer side effects. Other options include immunotherapy and NanoKnife technology for precise tumor destruction.
Bookimed Expert Insight: Israeli specialists often bridge the gap between palliative care and aggressive surgery by combining techniques. Dr. Almog Ben Yaacov at Sheba Medical Center has performed over 200 HIPEC procedures. His training includes NanoKnife and microwave ablation. This allows for a tiered approach. If a patient is ineligible for full cytoreduction, specialists may use these focal technologies instead of traditional open surgery.
Patient Consensus: Patients emphasize the importance of getting a Peritoneal Cancer Index (PCI) score quickly. They note that catching the disease when the score is under 10 often opens doors to these less invasive, life-extending protocols.
Sheba Medical Center and Sourasky Medical Center are the primary Israeli facilities specializing in cytoreductive surgery and HIPEC. These JCI-accredited institutions utilize multidisciplinary teams to treat abdominal carcinomatosis. Expertise is concentrated in Tel Aviv and Ramat Gan with surgeons trained at top international oncology centers.
Bookimed Expert Insight: While many select hospitals based on general reputation, the volume of procedures is a stronger indicator of safety for HIPEC. At Sheba Medical Center, oncology specialists manage over 2 million patients annually. This high-volume environment allows surgeons like Dr. Almog Ben Yaacov to maintain specialized skill sets in complex CRS+HIPEC protocols that smaller facilities may not match.
Patient Consensus: Patients note that Israeli oncology protocols are often more aggressive than those in other countries. They emphasize the importance of confirming a surgeon's individual case volume rather than just the hospital's general ranking.
International patients can receive a preliminary carcinomatosis treatment plan in Israel through telemedicine and digital record review. Specialists use high-resolution imaging and pathology reports to assess candidacy for procedures like HIPEC. While not a final contract, these plans help confirm diagnostic accuracy and estimate required medical travel budgets.
Bookimed Expert Insight: While preliminary plans are available, large centers like Sheba and Sourasky often emphasize that a physical examination is vital for staging. For instance, packages at Sheba Medical Center include specific on-site diagnostics like cancer markers and PET/CT to confirm the final surgical roadmap. This is because carcinomatosis requires a precise assessment of disease spread that even high-quality scans may not fully capture remotely.
Patient Consensus: Patients note that while video calls are helpful for initial direction, surgeons usually require a 3 to 5 day in-person visit for staging before performing HIPEC. They also suggest requesting a written summary after virtual consults to simplify insurance pre-approval and visa applications.
Follow-up therapies in Israel after HIPEC focus on clinical monitoring and systemic adjuvant care to prevent recurrence. Patients undergo routine PET-CT scans and blood tests for tumor markers. Dedicated teams at JCI-accredited centers provide specialized nutritional support and physical therapy during the standard 3-to-6 month recovery period.
Bookimed Expert Insight: While most packages focus on the surgery itself, top-tier Israeli centers like Sheba Medical Center often include up to 14 days of hotel stay for long-term monitoring. This ensures specialists like Dr. Almog Ben Yaacov, who has performed 200+ procedures, can personally oversee the critical initial recovery phase. Checking for included hotel stays can reduce logistical stress during early follow-up.
Patient Consensus: Patients emphasize the need for direct communication with the surgical team regarding post-op protocols. Many find that specialized dietary support is essential during the two weeks of intravenous nutrition often required after surgery.